Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT

被引：0
|
作者：
Florman, S. [1 ]
Bray, R. [2 ]
Gebel, H. [2 ]
Kuypers, D. [3 ]
Larsen, C. [2 ]
Medina Pestana, J. [4 ]
Rial, M. [5 ]
Rostaing, L. [6 ]
Wekerle, T. [7 ]
Grannas, G. [8 ]
Meier-Kriesche, U. [9 ]
Polinsky, M. [9 ]
Townsend, R. [9 ]
Munier, S. [9 ]
Grinyo, J. [10 ]
Durrbach, A. [11 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Hosp Rim, Sao Paulo, Brazil
[5] Inst Nefrol, Buenos Aires, DF, Argentina
[6] Univ Hosp, Toulouse, France
[7] Med Univ Vienna, Vienna, Austria
[8] Hannover Med Sch, D-30623 Hannover, Germany
[9] Bristol Myers Squibb, Lawrenceville, NJ USA
[10] Univ Hosp Bellvitge, Barcelona, Spain
[11] Univ Hop Bicetre, Villejuif, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P-45
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [31] Renal Function in Patients Treated with Belatacept- or Cyclosporine-Based Regimens at Year 3 in the BENEFIT and BENEFIT-EXT Studies
    Durrbach, A.
    Citterio, F.
    Mulloy, L.
    David-Neto, E.
    Russ, G.
    Vitko, S.
    Zhang, R.
    Xing, J.
    Harler, M. B.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 100 - 100
  • [32] 5-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY
    Muehlbacher, Ferdinand
    Florman, Sander
    Zhang, Rubin
    Lang, Philippe
    Lehner, Frank
    Massari, Pablo
    Garcia, Valter D.
    Pupim, Lara
    Durrbach, Antoine
    TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
  • [33] Five-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
    Durrbach, A.
    Florman, S.
    Zhang, R.
    Lang, P.
    Lehner, F.
    Massari, P.
    Garcia, V.
    Pupim, L.
    Muehlbacher, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 311
  • [34] SUPERIOR ESTIMATED GFR ASSOCIATED WITH BELATACEPT VS. CYCLOSPORINE TREATMENT: RESULTS FROM A MIXED EFFECTS MODELING ANALYSIS OF THE BENEFIT-EXT STUDY
    Durrbach, Antoine
    Medina, Pestana Jose
    Del Carmen, Rial Maria
    Grannas, Gerrit
    Matas, Arthur
    Polinsky, Martin
    Meier-Kriesche, Herwig-Ulf
    Munier, Stephane
    Grinyo, Josep
    TRANSPLANT INTERNATIONAL, 2015, 28 : 83 - 84
  • [35] Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies.
    Durrbach, A.
    Florman, S.
    Zhang, R.
    Becker, T.
    Grinyo, J.
    Lang, P.
    Garcia, V. D.
    Duan, T.
    Pupim, L.
    Medina Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 407 - 407
  • [36] Impact of Donor Age on Three-Year Outcomes in Recipients of Extended Criteria Kidneys Treated with Belatacept vs Cyclosporine in BENEFIT-EXT Trial.
    Budde, K.
    Morales, J.
    Blancho, G.
    Muehlbacher, F.
    Lehner, F.
    Rice, K.
    Pupim, L.
    Aigner, S.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 182 - 183
  • [37] Outcomes as a Function of Donor Criteria from a Phase III Study of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT-EXT).
    Florman, Sander
    Durrbach, Antoine
    Larsen, Christian
    Pestana, Jose Medina
    Vanrenterghem, Yves
    Vincenti, Flavio
    Block, Alan
    Garg, Pushkal
    Copley, J. Brian
    Xing, Jun
    Grinyo, Josep
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 150 - 150
  • [38] LONG-TERM RESULTS OF CYCLOSPORINE-TREATED RENAL-TRANSPLANTS
    ALKHADER, AA
    ALSULAIMAN, MH
    MOUSA, DH
    BOUBENIDER, S
    DHAR, JM
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 31 - 33
  • [39] BELATACEPT TREATED PATIENTS EXPERIENCE IMPROVED HEALTH-RELATED QUALITY OF LIFE AND LOWER SYMPTOM DISTRESS COMPARED TO CYCLOSPORINE TREATED PATIENTS: AN ANALYSIS OF THE BENEFIT AND BENEFIT-EXT COHORTS
    Everly, M. J.
    Purnajo, L.
    Beaumont, J.
    Polinsky, M.
    Alemao, E.
    Durrbach, A.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 12 - 13
  • [40] EVALUATION OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT PATIENTS TREATED WITH BELATACEPT- OR CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN BENEFIT AND BENEFIT-EXT
    Larsen, Christian P.
    Bray, Robert
    Gebel, Howard
    Ganguly, Bishu
    Kulbokas, Ej
    Brickman, Daniel
    Duan, Tao
    Townsend, Robert
    TRANSPLANT INTERNATIONAL, 2011, 24 : 69 - 69
12345